FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3023911000001107: Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 22-Jun 2016. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    17617101000001111 Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    38140001000001114 Relifex 500mg/5ml oral suspension (Meda Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) Is a Product containing precisely nabumetone 100 milligram/1 milliliter conventional release oral suspension false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) Has active ingredient Nabumetone false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) Is a Relifex false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) Has specific active ingredient Nabumetone false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) Has dispensed dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Is pack of False Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Has AMP False Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start